To assess the benefits and harms of adefovir dipivoxil alone or in combination with other drugs, as compared with no treatment or placebo in the treatment of patients with chronic hepatitis B virus infection.
This is a protocol.
Adefovir dipivoxil for chronic hepatitis B
You may also be interested in:
- Evidence on beneficial or harmful effects of bicyclol for chronic hepatitis C is not found
- Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinoma
- Glucocorticosteroid pretreatment may increase virologic response to interferon in hepatitis B 'e' antigen positive chronic hepatitis B
- Hepatitis B immunoglobulin (HBIG) during pregnancy for the prevention of mother-to-child transmission of hepatitis B virus (HBV)
- Bile acids may improve liver biochemistry of patients with hepatitis B or C, but there is insufficient evidence about long-term beneficial effects
Health topics: